Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

CRISPR technology, a revolutionary tool in genetic engineering, has empowered Lambert's iGEM team to tackle a significant health issue: Lyme disease, which affects nearly half a million Americans ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now. Citizens reaffirmed its ...

The gene editing market is experiencing significant growth, with a projected annual growth rate (CAGR) of 16-18% in the coming years. This expansion is fueled by breakthroughs in gene-editing ...

For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...

Promoting innovation through capital-market innovation and regulatory modernisation, like China did, is the way to go ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

Cancer is a leading cause of death worldwide, and among all cancers, colorectal cancer ranks second in mortality, responsible ...

A new study describes a key molecular mechanism that explains how cells exchange information through extracellular vesicles ...

Teens at a Georgia high school may have come up with a better way to detect and treat Lyme disease. They took their idea to ...

Reviving lost species may help restore ecosystems, but it demands robust scientific oversight to ensure responsible use ...